Atrial and ventricular septal defects can safely be closed by percutaneous intervention (Q36335201)

13 August 2017

1 reference

title

Atrial and ventricular septal defects can safely be closed by percutaneous intervention (English)

1 reference

13 August 2017

2

Franziska Büscheck

1 reference

13 August 2017

Ralph Hein

1

1 reference

13 August 2017

Evelyn Fischer

3

1 reference

13 August 2017

Michaela Leetz

4

1 reference

13 August 2017

Margareth Taaffe Yves Bayard

5

1 reference

13 August 2017

Stefan Ostermayer

6

1 reference

13 August 2017

Madlen Reschke

7

1 reference

13 August 2017

Klaus Lang

8

1 reference

13 August 2017

Albrecht Römer

9

1 reference

13 August 2017

Neil Wilson

10

1 reference

13 August 2017

Horst Sievert

11

1 reference

13 August 2017

publication date

1 December 2005

1 reference

Journal of Interventional Cardiology

13 August 2017

published in

1 reference

13 August 2017

volume

18

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

515-522

1 reference

Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2005.00094.X

Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2005.00094.X

Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2005.00094.X

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2005.00094.X

Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2005.00094.X

Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2005.00094.X

Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2005.00094.X

Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2005.00094.X

Association of interatrial shunts and migraine headaches: impact of transcatheter closure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2005.00094.X

Migraine headache relief after transcatheter closure of patent foramen ovale

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2005.00094.X

Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2005.00094.X

Early and late complications associated with transcatheter occlusion of secundum atrial septal defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2005.00094.X

Single-center experience with the HELEX septal occluder for closure of atrial septal defects in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2005.00094.X

Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2005.00094.X

Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2005.00094.X

[Transcatheter closure of congenital ventricular septal defects]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2005.00094.X

Transcatheter device closure of congenital and postoperative residual ventricular septal defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2005.00094.X

Transcatheter closure of congenital muscular ventricular septal defect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2005.00094.X

Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2005.00094.X

Percutaneous closure of congenital and acquired ventricular septal defects--considerations on selection of the occlusion device.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2005.00094.X

10.1111/J.1540-8183.2005.00094.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference